戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 -mesenchymal transition and proliferation of mesenchymal cells.
2 differentiation and mineralization of dental mesenchymal cells.
3 ogenitor cells, mature neurons or epithelial-mesenchymal cells.
4 as up-regulated by DSP (aa183-219) in dental mesenchymal cells.
5 s expression of CD31, VeCadherin, or Tie2 in mesenchymal cells.
6 1 expression was induced in nonproliferative mesenchymal cells.
7 yllium, it did disrupt cell proliferation in mesenchymal cells.
8 eas others reflect the phenotypes of stem or mesenchymal cells.
9 orming growth factor (TGF)-beta signaling in mesenchymal cells.
10 lammation by inducing cytokine production by mesenchymal cells.
11 notypic conversion of endothelial cells into mesenchymal cells.
12  promoter during myogenic differentiation of mesenchymal cells.
13 ntron of LEF1 gene and undergoes splicing in mesenchymal cells.
14 iferation, migration, and differentiation of mesenchymal cells.
15 e and express markers of both epithelial and mesenchymal cells.
16 s, c-src was constitutively activated in mes mesenchymal cells.
17 e collagen I more efficiently than elongated-mesenchymal cells.
18  rapidly migrating leukocytes to slow-moving mesenchymal cells.
19 ssociated with a failure in apoptosis of the mesenchymal cells.
20 tiation of human embryonic stem cell-derived mesenchymal cells.
21 s known to induce expression of NOX4 mRNA in mesenchymal cells.
22  throughout the genome of human bone explant mesenchymal cells.
23 accumulation of activated collagen-producing mesenchymal cells.
24 r the differentiation of vascular-associated mesenchymal cells.
25  secretion by osteoblasts, chondrocytes, and mesenchymal cells.
26  little is known regarding their function in mesenchymal cells.
27 mised the migratory and invasive behavior of mesenchymal cells.
28 main A and Toll-like receptor 4 expressed in mesenchymal cells.
29 nd AEC1s), capillaries, and various resident mesenchymal cells.
30 ooth muscle lineage in C3H10T1/2 pluripotent mesenchymal cells.
31 parative processes, and serve as pluripotent mesenchymal cells.
32 ytotoxicity against nontransformed blood and mesenchymal cells.
33 converts epithelial cells into highly motile mesenchymal cells.
34 ssing phenotypic markers for endothelial and mesenchymal cells.
35 dependent set of sorted, primary MDS-derived mesenchymal cells.
36 tors are required to activate Hoxd13 in limb mesenchymal cells.
37 ls into the front-rear polarity of migrating mesenchymal cells.
38 dipogenic differentiation in the pluripotent mesenchymal cells.
39 riptional program, and transdifferentiate to mesenchymal cells.
40 g DLX5, DLX6 and HAND2, were also reduced in mesenchymal cells.
41 mp1 gene expressions in mouse dental papilla mesenchymal cells.
42  prominent clustering of the adjacent dermal mesenchymal cells.
43 ltered differentiation outcomes specified by mesenchymal cells.
44 ce mineral formation of mouse dental papilla mesenchymal cells.
45 e tooth development and mouse dental papilla mesenchymal cells.
46 ose tissue and primarily in undifferentiated mesenchymal cells.
47 independent endothelial marker expression in mesenchymal cells.
48 d the transition from endothelial cells into mesenchymal cells, a critical step in heart valve develo
49 duced canonical WNT signaling in neighboring mesenchymal cells, a phenotype reproduced by endocardial
50 -Os), a surrogate marker of undifferentiated mesenchymal cells able to differentiate to osteoblasts,
51  senescent cholangiocytes promoted quiescent mesenchymal cell activation in a platelet-derived growth
52 ochemical properties as force transducers in mesenchymal cell aggregates, we show that the magnitude
53                       Gorab-deficient dermal mesenchymal cells also displayed a significantly reduced
54  posttranslational change in microtubules in mesenchymal cells alters the mesenchymal microenvironmen
55 re the cellular metabolome of epithelial and mesenchymal cells, an in vitro model used to study cance
56                   Importantly, expression of mesenchymal cell and cholangiocyte marker was significan
57 f FZHY's role is to inhibit the formation of mesenchymal cells and cholangiocytes.
58 ine the age-dependent contribution of native mesenchymal cells and circulating factors on in vivo bon
59  expression, disaggregation of BMP4-positive mesenchymal cells and loss of Shh in the eyelid epitheli
60 ransdifferentiation of epithelial cells into mesenchymal cells and myofibroblasts plays an important
61 1 as a microenvironmental factor produced by mesenchymal cells and overexpressed in bones of a subset
62 ity resulted in premature differentiation of mesenchymal cells and reduced vasculogenesis of the sple
63 propriate nature of the interactions between mesenchymal cells and surrounding/underlying matrix/subs
64  for osteochondroprogenitors within CD105(+) mesenchymal cells and that these cells readily form bone
65 ophage motility contributes to the number of mesenchymal cells and ultimate scar size following cutan
66 leukocytes, extracellular matrix components, mesenchymal cells, and a collection of nerves, blood, an
67 oorly differentiated, migratory and invasive mesenchymal cells, and it has been related to the metast
68 sarcoma subtypes compared with non-malignant mesenchymal cells, and knockdown of DDX3 by RNA interfer
69 ganoids cocultured with immortalized stomach mesenchymal cells, antagonists of WNT and Smoothened inh
70                                 Pro-fibrotic mesenchymal cells are known to be the key effector cells
71    Our results indicate that CD34(+) Gp38(+) mesenchymal cells are programmed to develop in the intes
72                               Although these mesenchymal cells are reported to have multiple embryoni
73 hesis raises the question whether changes in mesenchymal cells are the cause and/or the consequences
74 Genetic lineage tracing confirmed that these mesenchymal cells arose, in part, through a process of e
75 mechanism is only present in non-transformed mesenchymal cells as collagen-induced MT1-MMP activation
76                          Wall degradation of mesenchymal cells, as well as motility of both types of
77     Alveolar fibrocytes are monocyte-derived mesenchymal cells associated with poor prognosis in pati
78 mal cell differentiation from endothelial to mesenchymal cells, associated with a lack of extracellul
79 P is crucial for the proliferation of dental mesenchymal cells, because either inhibition with Hh inh
80 w increasing our understanding of intestinal mesenchymal cell biology and function could lead to new
81             We discovered that the condensed mesenchymal cell bodies (CMBs) formed in vitro set an ou
82 ta signaling suppresses transition of MCs to mesenchymal cells both in vitro and in vivo.
83 ritical for supporting cell proliferation in mesenchymal cells both in vivo and in vitro beta1 integr
84  that TACC2 can promote MT polymerization in mesenchymal cells but not neuronal growth cones, thus di
85                      Increased HA levels and mesenchymal cells, but not vascular endothelial growth f
86 that fibrocytes do not transform into WT1(+) mesenchymal cells, but they do augment accumulation of W
87 esists physical forces, with tendon-specific mesenchymal cells called tenocytes orchestrating extrace
88 of the hGH minigene in CollagenVI expressing mesenchymal cells can lead through local and/or systemic
89 . (2017) show that exosomal miRs secreted by mesenchymal cells can regulate epithelial KIT(+) progeni
90 hesions and under conditions of confinement, mesenchymal cells can spontaneously switch to a fast amo
91 oteins coordinate the specific shortening of mesenchymal cell-cell contacts, which in turn powers cel
92 tify pericryptal CD34(+) Gp38(+) alphaSMA(-) mesenchymal cells closely associated with Lgr5(+) IESCs.
93 m rapidly adhering (RA) fractions of cardiac mesenchymal cells (CMCs) are effective in preserving lef
94 ar matrix (ECM) constructed by AKAP12+ colon mesenchymal cells (CMCs) generated M2 macrophages by reg
95 es-associated alterations present in cardiac mesenchymal cells (CMSC) obtained from normoglycemic (ND
96                     RATIONALE: Human cardiac mesenchymal cells (CMSCs) are a therapeutically relevant
97 rentiation in vitro and in vivo by promoting mesenchymal cell compaction as seen in each pore of the
98 CUX1 to Snail and the E-cadherin promoter in mesenchymal cells compared to epithelial prostate and br
99                     Expression of miR-203 in mesenchymal cells compromises migratory and invasive cap
100       Using time-lapse imaging, we find that mesenchymal cell condensation at hair follicles is local
101 ning subsets of hematopoietic cells, and how mesenchymal cells contribute to other stem cell niches.
102 herogenesis, but it is unclear whether other mesenchymal cells contribute to this process.
103  reveals that Bmp signaling in Hh-responsive mesenchymal cells controls cluster pattern.
104 in media collected from immortalized stomach mesenchymal cells correlated with increased expression o
105  cooperation emerges in mid-level energy, as mesenchymal cells create paths that are used by amoeboid
106  repertoire of HLA class I-bound peptides in mesenchymal cells deficient in immunoproteasome componen
107  presence of untranslated YKL-40 mRNA in non-mesenchymal cells derived from MSCs reflects differences
108 ) during osteogenic differentiation of human mesenchymal cells derived from the stromal vascular frac
109 g three-dimensional extracellular matrix and mesenchymal cells derived from the tumor microenvironmen
110 tion of LPS-treated primary mouse fetal lung mesenchymal cells detected increased interactions betwee
111 ere saccular phenotype, including defects of mesenchymal cell development and remodeling of the dista
112           This DSP domain facilitates dental mesenchymal cell differentiation and mineralization.
113 ver, mechanisms of DSP in controlling dental mesenchymal cell differentiation are unknown.
114 cific expression analyses revealed that Cpdm mesenchymal cells display increased responsiveness towar
115                                              Mesenchymal cells displayed distinct molecular profiles
116 l state change that transforms epithelial to mesenchymal cells during embryonic development, adult ti
117 DSP, occludin and FAK was detected in dental mesenchymal cells during tooth development.
118 ct was attributed primarily to inhibition of mesenchymal cell expansion.
119                      Similarly, vascular and mesenchymal cells express BMPs in various places and at
120 ined in co-culture with immortalized stomach mesenchymal cells express robust numbers of surface pit,
121  differentiate as inner eyelids and adjacent mesenchymal cells express Spry1 and Spry2 prior to eyeli
122            In the fetal pancreas, peripheral mesenchymal cells expressed Sema3a, while central nascen
123 al tissue demonstrates that undifferentiated mesenchymal cells expressing high levels of beta-catenin
124                                              Mesenchymal cells expressing platelet-derived growth fac
125  of a potent epigenetic switch that controls mesenchymal cell fate into myogenic and osteogenic linea
126 ther extracellular matrix gene production by mesenchymal cells from both murine and human fibrotic lu
127 rospectively identified, sorted and expanded mesenchymal cells from human primary NSCLC samples based
128 t not mPtch1 were present in primary mammary mesenchymal cells from mes mice, whereas the expression
129 i containing whole chromosomes were found in mesenchymal cells from most groups of offspring at the 3
130 tested its activity on committed preskeletal mesenchymal cells from mouse embryo limb buds and whole
131 with Sonic Hedgehog (Shh) of primary mammary mesenchymal cells from wild-type and mes animals activat
132  changes such as loss of 10p in disseminated mesenchymal cells generate epithelial variants, which ca
133 iated by immune cell function independent of mesenchymal cell Hox5 family function.
134 l cancer, we show that IKKbeta in intestinal mesenchymal cells (IMCs) is critically involved in colit
135 cess is operational in airway epithelial and mesenchymal cells in asthma.
136            These data indicate that specific mesenchymal cells in bone marrow provide key molecular d
137 alysis was used to investigate the origin of mesenchymal cells in fibrotic allografts.
138 hat WT1 is expressed by both mesothelial and mesenchymal cells in idiopathic pulmonary fibrosis lungs
139                            The importance of mesenchymal cells in inflammation and/or neoplastic tran
140 of chondrogenic and matrix genes in limb bud mesenchymal cells in micromass culture.
141    These secreted factors are upregulated in mesenchymal cells in response to serum withdrawal, and o
142  cells in epithelial tissues, are markers of mesenchymal cells in the adult lung.
143 t a similar dynamic exists between AEC2s and mesenchymal cells in the human lung.
144                                              Mesenchymal cells in the intestine comprise a variety of
145 oregulatory circuits engaging epithelial and mesenchymal cells in the intestine, airways, and skin an
146 s of epithelial Fgf8 expression and death of mesenchymal cells in the mandibular arch without affecti
147 elet-derived growth factor receptor alpha(+) mesenchymal cells in the stroma.
148                                              Mesenchymal cells in tumors, called cancer-associated fi
149 with osterix(+) osteoblast-lineage committed mesenchymal cells in wild-type mice.
150 ive inhibition of RANKL in hematopoietic vs. mesenchymal cells, in conjunction with in situ expressio
151                                 Importantly, mesenchymal cells including fibroblasts are prominent in
152 lineage tracing demonstrated that mesodermal mesenchymal cells including HSCs are the major source of
153                                              Mesenchymal cells including microvascular mural cells (p
154                PDGFR-beta promotes growth of mesenchymal cells, including blood vessels and smooth mu
155 on surgery-mediated liver injury, mesodermal mesenchymal cells, including HSCs and PFs, differentiate
156  whereas the numbers of both endothelial and mesenchymal cells increase substantially from birth to e
157 ort that hyperacetylation of microtubules in mesenchymal cells increased cytokeratin 14-positive (K14
158 type, whereas knocking down the ZEB1 gene in mesenchymal cells induced an epithelial phenotype, demon
159 h as hematopoietic stem cell transplants and mesenchymal cell infusions.
160  that NO66 overexpression in Prx1-expressing mesenchymal cells inhibited skeletal growth and bone for
161 crucial in initiating the differentiation of mesenchymal cells into chondrocytes, but whether voltage
162 does not alter the timely differentiation of mesenchymal cells into chondrocytes.
163 rthermore, differentiation of the mesodermal mesenchymal cells into oval cells was not observed.
164 el, Klar et al. incorporated adipose-derived mesenchymal cells into skin substitutes and found that a
165 pathology demonstrated migration of resident mesenchymal cells into the scaffold and trilaminar ECM o
166  epithelial to mesenchymal transition (EMT), mesenchymal cells invade the myocardium to form coronary
167 d for 2D cell migration but is essential for mesenchymal cell invasion in 3D culture and in a mouse c
168                                  Directional mesenchymal cell invasion in vivo is understood to be a
169 skeletal dynamics and migration signaling in mesenchymal cell invasion.
170 Dlg1 expression in ureter and CND-associated mesenchymal cells is essential for ensuring distal urete
171  of TGF-beta1 to modulate DNA methylation in mesenchymal cells is less clear.
172 ransdifferentiation of epithelial cells into mesenchymal cells, is critical for embryonic development
173 senchymal transition, resulting in increased mesenchymal cells, is the likely cause of morphological
174 anoids co-cultured with immortalized stomach mesenchymal cells (ISMCs).
175 mma that drives expression of B7-H1 on graft mesenchymal cells leading to Tef cell apoptosis.
176 Conditional inactivation of Gata4 in hepatic mesenchymal cells led to embryonic lethality around mous
177 epithelial cell-restricted miR-200 family in mesenchymal cells limited mTOR signaling and sensitized
178 ased number of peptides are detected for the mesenchymal cell line relative to the epithelial cell in
179 -regulated the Dspp promoter activities in a mesenchymal cell line.
180 bryonic mouse lung at E16.5 to identify lung mesenchymal cell lineage relationships that currently re
181                     It is involved in dental mesenchymal cell lineages and dentin formation through r
182 ion of ECM production in the endocardial and mesenchymal cell lineages of the developing heart.
183 ple subpopulations of immune, epithelial and mesenchymal cell lineages.
184   Here we established one epithelial and two mesenchymal cell lines from ascites of a bladder cancer
185  their upregulation in metastatic tumors and mesenchymal cell lines is coordinated to that of collage
186 in-binding proteins, a signature shared with mesenchymal cell lines.
187  (>15% per year) and more limited renewal of mesenchymal cells (<4% per year in adulthood).
188                 Genetic loss of Hif1alpha in mesenchymal cells marked by Prx-cre prevents the formati
189               The cells also expressed known mesenchymal cell markers and promoted new bone formation
190  between expanding epithelial and background mesenchymal cells may be maintained, in part, by inhibit
191 ch as Mst and Taok family of MAPK kinases in mesenchymal cells) may represent novel targets that warr
192                    Fibrotic diseases display mesenchymal cell (MC) activation with pathologic deposit
193 s, FH-iPSC +/- LDLR were differentiated into mesenchymal cells (MC), pretreated with excess free ster
194                                              Mesenchymal cells (MCs) derived from fibrotic lung allog
195           In order to understand the role of mesenchymal cells (MCs) in the adult thymus, we performe
196 equires communication between epithelial and mesenchymal cells, melanocytes, and neurons.
197 mesenchymal transformation and the resulting mesenchymal cells migrate out laterally to form mesoderm
198 root formation is a dynamic process in which mesenchymal cells migrate toward the site of the future
199 inases that are important for epithelial and mesenchymal cell migration.
200 tion of PKCvarepsilon is sufficient to block mesenchymal cell morphology.
201                                              Mesenchymal cell motility is driven by polarized actin p
202 t is differentially up-regulated in alveolar mesenchymal cells of human subjects with rapidly progres
203 ce was reduced in both white blood cells and mesenchymal cells of RCPS-affected individuals as compar
204 ncludes endocardial and neural crest derived mesenchymal cells of the cardiac cushions, neural crest-
205              In contrast, deletion of Wls in mesenchymal cells of the developing lung did not alter b
206 roenvironmental components such as immune or mesenchymal cells on epithelial cell types of origin for
207                                          The mesenchymal cells on the other hand, exhibited constitut
208 ut (CKO) of Notch1 in collagen I-expressing (mesenchymal) cells on treatment with tamoxifen (Notch1 C
209        Invasion can occur either by isolated mesenchymal cells or by aggregates that migrate collecti
210         When Foxc1 was deleted in all marrow mesenchymal cells or CAR cells, from embryogenesis onwar
211 A may be a better choice in situations where mesenchymal cells or inflammatory cells are significantl
212 ic ablation of alpha6 in collagen-expressing mesenchymal cells or pharmacological blockade of matrix
213       Our results supported a resident liver mesenchymal cell origin of the TDFSM cells, which were n
214 mors induced by MPyV from an epithelial to a mesenchymal cell origin.
215 t cell count (P = 0.04); 2) lower density of mesenchymal cells (P = 0.05); and 3) more diffuse, non-l
216                                              Mesenchymal cells, Paneth cells, immune cells, endotheli
217  is duplicated and surrounding Pax2-positive mesenchymal cells persist in the nephric cord, suggestin
218 alcium from its body cavity into the primary mesenchymal cells (PMCs) that are responsible for spicul
219 rat hepatic stellate cells, a resident liver mesenchymal cell population, in hosts that have suffered
220 ibroblasts, arise via activation of resident mesenchymal cell populations and the recruitment of bone
221                        These closely related mesenchymal cell populations form extensive connections
222 tified as distinct pluripotent stem cells in mesenchymal cell populations in humans.
223 y refers to the pairing of hematopoietic and mesenchymal cell populations that regulate HSC self-rene
224 controlled by the interacting epithelial and mesenchymal cell populations.
225 n to be important in lung development within mesenchymal cell populations.
226 endothelial, smooth muscle, hematopoietic or mesenchymal cell progeny.
227 ntegrity to expedite migration could inhibit mesenchymal cell proliferation in a secondary tumor as i
228  found them linked to positive regulation of mesenchymal cell proliferation in LNCaP and C4-2B, and s
229 is DSP domain induces endogenous dental pulp mesenchymal cell proliferation, differentiation and migr
230 epithelial-mesenchymal transformation (EMT), mesenchymal cell proliferation, valve elongation and rem
231 ditional genetic loss of Ezh2 in uncommitted mesenchymal cells (Prrx1-Cre) results in multiple defect
232 h in vitro cell expansion of embryonic tooth mesenchymal cells renders them unable to induce tooth fo
233 hat ITGB4(+) cancer stem cell (CSC)-enriched mesenchymal cells reside in an intermediate epithelial/m
234 equired in endocardial cells to regulate the mesenchymal cell responses that remodel cardiac cushions
235 ependent Collagen I production in intestinal mesenchymal cells result in fibrosis in patients with Mo
236      By using an inducible Cre model to mark mesenchymal cells (Scx-creERT/tdTomato + ) prior to inju
237 n substitutes and found that adipose-derived mesenchymal cells secreted high levels of transforming g
238 phe inhibition by SLAIN2 and CLASP1 supports mesenchymal cell shape in soft 3D matrices by enabling m
239 lar structure (1 mm i.d.) from aligned human mesenchymal cell sheets (hMSC) as the wall and human end
240 e, quantification of cell polarity in facial mesenchymal cells showed that while orientation of the G
241                                           In mesenchymal cells, Sp1 expression is maintained, but its
242 ess the human TNFR1 under the control of the mesenchymal cell-specific CollagenVI promoter.
243 both WT mice and animals harboring a uterine mesenchymal cell-specific Med12 deletion.
244                     We review the intestinal mesenchymal cell-specific pathways that regulate these p
245 rly characterize this therapy-resistant high-mesenchymal cell state in human cancer cell lines and or
246                                       A high-mesenchymal cell state observed in human tumours and can
247 herapy-resistant cancer cells across diverse mesenchymal cell-state contexts.
248 ication of mechanical stretch to multipotent mesenchymal cells stimulated the nuclear translocation o
249 er, these two miRNAs are highly expressed in mesenchymal cells such as fibroblasts and smooth muscle
250 olling the directed migration of slow-moving mesenchymal cells such as fibroblasts are not well under
251                                              Mesenchymal cells such as fibroblasts are weakly polariz
252 work integrating beta-catenin/SHH signals in mesenchymal cell survival and outgrowth of the mandible
253 at in neural crest-derived craniofacial ecto-mesenchymal cells, Tak1 is not only required for TGF-bet
254 ts suggest that in neural crest-derived ecto-mesenchymal cells, Tak1 provides a critical point of int
255                              In craniofacial mesenchymal cells, Tak1 regulates both R-Smad C-terminal
256          The neural crest is a population of mesenchymal cells that after migrating from the neural t
257 stoma is a rare childhood malignancy of lung mesenchymal cells that can remain dormant as epithelial
258 ately reprogrammed stem cells (iRSCs), human mesenchymal cells that express exogenous Oct4, Sox2, Klf
259                       BMP-4 was expressed in mesenchymal cells that expressed alpha-smooth muscle act
260 ice to inactivate Fam20C in the craniofacial mesenchymal cells that form dentin and alveolar bone.
261               Osteoblasts are differentiated mesenchymal cells that function as the major bone-produc
262 on, expand, and form an extensive lineage of mesenchymal cells that have characteristics of pericytes
263 +) cells indigenous to the ovary and Gli1(+) mesenchymal cells that migrate from the mesonephros.
264    Hepatic stellate cells are liver-specific mesenchymal cells that play vital roles in liver physiol
265 en receptor (Ar) identify a subpopulation of mesenchymal cells that regulate sinus ridge morphogenesi
266         In spiders, a group of BMP secreting mesenchymal cells (the cumulus) functions as an organize
267 s, including IL-6, are produced by activated mesenchymal cells themselves and activate STAT3.
268 an promoting the generation of single, fully mesenchymal cells, this reduction of membrane N-cadherin
269 ble plasticity, having the ability to become mesenchymal cells through alterations in adhesion and mo
270 r of dental stem cells and miR-200a converts mesenchymal cells to a fully differentiated dental epith
271 elial cell differentiation and conversion of mesenchymal cells to amelogenin expressing epithelial ce
272 helial cells modulate their interaction with mesenchymal cells to generate a dynamically changing pro
273 selectively activate mucosal endothelial and mesenchymal cells to promote specific angiogenic respons
274 onstrates the conserved ability of different mesenchymal cells to respond to these genitalia-inducing
275 n of histone marks during differentiation of mesenchymal cells to the osteogenic and myoblastic linea
276 nd then cocultured with immortalized stomach mesenchymal cells, to assess proliferative responses to
277                                Epithelial to mesenchymal cell transition (EMT), whereby fully differe
278 tracellular matrix remodeling, epithelial-to-mesenchymal cell transitions, and cell proliferation.
279 d tissue from surgical biopsies that include mesenchymal cells transplanted on biodegradable scaffold
280 ctivation of NLRP3 in myeloid cells, but not mesenchymal cells triggers chronic inflammation, which u
281                    Fibroblasts are the major mesenchymal cell type in connective tissue and deposit t
282                             The diversity of mesenchymal cell types in the lung that influence epithe
283 ostasis, proliferation of all epithelial and mesenchymal cell types remained low but intermediate cel
284                 Contrary to that observed in mesenchymal cell types, here NOX4 suppresses Rho and Cdc
285 issues and trans-differentiate into some non-mesenchymal cell types.
286 lial cells (MCs) differentiate into specific mesenchymal cell types; however, the contribution of thi
287 understand the role of Vhl in the biology of mesenchymal cells, we analyzed mutant mice lacking Vhl i
288 l properties of cartilage derived from human mesenchymal cells were comparable to native cartilage, w
289 Exosomes derived from normal fibroblast-like mesenchymal cells were engineered to carry short interfe
290 ssed mesenchymal and epithelial markers, but mesenchymal cells were highly enriched in CTCs.
291 d cell fate, oral epithelial and odontoblast mesenchymal cells were reprogrammed by a two-step induct
292 ta-catenin signaling is activated in cushion mesenchymal cells where it supports FGF-driven expansion
293 row derived mononuclear cells, or autogenous mesenchymal cells, which can be administered as cryopres
294  was developed whereby transduction of these mesenchymal cells with adenoviruses containing Pdx1, Ngn
295 dogenous repair factor secreted primarily by mesenchymal cells with effects on cells expressing its r
296 HEFs and HEMCs increased after incubation of mesenchymal cells with eosinophil-derived products, and
297                                              Mesenchymal cells with properties of activated repair ce
298  and increasing BMP4 production by patients' mesenchymal cells with resistance.
299                                 Treatment of mesenchymal cells with the Cat L inhibitor Z-FY-CHO led
300 ated in the nuclei of ureteric, stromal, and mesenchymal cells within dysplastic human kidney tissue.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top